World AMR Awareness Week 2023: Joining forces to combat Antimicrobial Resistance
21 Nov, 2023
As we observe World AMR Awareness Week (WAAW) 2023, the theme of “Preventing antimicrobial resistance together” serves as a stark reminder of the collective responsibility we all share in preserving the effectiveness of these…
Read More
Register for the NeoIPC webinar: “Role and potential of surveillance in preventing hospital-acquired infections among newborns”
17 Nov, 2023
Hospital-acquired infections pose a significant risk to the health and wellbeing of newborns, especially preterm babies. The NeoIPC Clinical Practice Network will be holding a webinar focusing on the role and potential of…
Read More
NeoIPC launches new surveillance toolkit to bolster infection prevention and control efforts in NICUs
09 Nov, 2023
The NeoIPC Consortium is proud to announce the launch of a new surveillance toolkit to help neonatal intensive care units (NICUs) track and prevent hospital-acquired infections (HAIs) in high-risk newborns,…
Read More
Penta’s Young Reporters project shortlisted for Pharma Marketing Excellence Awards
27 Oct, 2023
There is a growing need to ensure that knowledge generated from clinical trials is shared widely and accurately. However, young people often find themselves left out of this crucial exchange…
Read More
PentaTr@ining Uganda 2023: Empowering healthcare professionals
27 Oct, 2023
In the heart of Munyonyo, Uganda, on October 13-14, over 140 healthcare professionals and researchers gathered for our course, PentaTr@ining Uganda 2023. The bespoke two-day programme was a rich fusion…
Read More
D3 (PENTA 21) hosts investigators’ meeting in Uganda
24 Oct, 2023
The D3 (PENTA 21) investigators’ meeting took place in Uganda on 12 October 2023, bringing together partners from South Africa, Spain, Thailand, UK and Uganda to discuss progress, challenges and…
Read More
New Penta/EACS HIV treatment guidelines 2023 available
19 Oct, 2023
The Penta/EACS HIV treatment guidelines 2023 were launched on the 18th October 2023 at the EACS conference in Poland. Guidance on preferred and alternative first-line antiretroviral therapy (ART) have been updated…
Read More
What to expect at a PK study day
02 Oct, 2023
A new animated video aimed at study participants explains what happens during a pharmacokinetics (PK) study. The video, which is now available to watch online in Lugandan, Isizulu and English,…
Read More
D3 trial completes recruitment ahead of schedule!
14 Sep, 2023
The D3 trial is excited to announce that it has successfully completed recruitment in the trial at an exceptional speed. D3 is looking to see if a new tablet, a…
Read More
PediCAP trial completes recruitment, investigating more child-friendly treatment options for severe community-acquired pneumonia
01 Sep, 2023
The PediCAP team is pleased to report that the 1100 patients required for the main trial in this study have now been recruited. PediCAP is an innovative, EDCTP funded clinical…
Read More
Nominate now for the Penta Brighter Future Award: celebrating visionary healthcare heroes
28 Jul, 2023
Do you know someone making a significant difference in healthcare, particularly for women and children? The Penta Brighter Future Award is here to recognise and celebrate those unsung heroes who…
Read More
Penta leads new scientific collaboration to improve treatment and reduce mortality of neonatal sepsis in Africa
27 Jul, 2023
A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospital with sepsis…
Read More
Discovering Australia: a trip to the International Workshop on HIV Pediatrics 2023
27 Jul, 2023
A warm welcome to my blog, thank you for joining me for the conference adventures!!! Flying to Brisbane, was a beautiful journey, it was my first time going out of…
Read More
Gilead partners with CHAI and Penta to improve treatment and adherence rates among children with HIV in low and middle income countries
17 Jul, 2023
FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) is pleased to announce two public-private partnerships. The first will accelerate the development of an investigational dispersible pediatric formulation containing emtricitabine and…
Read More
Large-scale cohort research project invites researchers to participate in science challenge
17 Jul, 2023
ORCHESTRA opens doors to COVID-19 related data to selected scientists Verona 17/07/2023 – ORCHESTRA-Cohort is a multinational cohort research project on COVID-19 and its long-term sequelae. The collaborative data collection of…
Read More
Penta hosts workshops on long-acting injectable antiretrovirals for children and adolescents
05 Jul, 2023
Between the months of April and May 2023, Penta hosted advisory group meetings where young people between the ages of 15 and 19 from South Africa, Argentina, the United Kingdom…
Read More
SMILE once-daily regimen non-inferior to triple ART regimen
28 Jun, 2023
Findings from the Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (PENTA-17) trial, simply known as SMILE, were published in eClinicalMedicine on 2 June 2023.…
Read More
Inaugural training session for UNIVERSAL’s Clinical Trial Management course
20 Jun, 2023
The inaugural Clinical Trial Management training program took place online on Wednesday, 14 June 2023, after 428 participants registered. The session was well attended by up to 168 clinical trial…
Read More